/Investor DB

Gilde Healthcare — 2020 Investments

4 investments dated 2020 · listed companies and verified rows first · show all

Acacia Pharmaeagleus.cominAug 2020

Eagle Pharmaceuticals develops and commercializes specialty pharmaceutical products for acute care and oncology, including injectable medications for procedural sedation, chemotherapy, lymphomas, and malignant hyperthermia management.

BiotechHealthtechMedical DevicesIndianapolis, US

Co-investorsF-Prime CapitalHercules Capital, Inc.O2h Ventures

LAVA Therapeuticslavatherapeutics.comin𝕏Sep 2020

LAVA develops the Gammabody platform, which generates bispecific antibodies that activate gamma-delta T cells to treat cancer by directing immune cells to tumors and triggering anti-cancer immune responses.

AI & Machine LearningBiotechHealthtechMedical Devices

Ton AdanginHans van der Vliet(Head of Innovation)inSteve Hurly(Chief Executive Officer)Oxana Polyakova(Chief Scientific Officer)in

Co-investorsMRL Ventures FundSanofi VenturesYsios CapitalNovo HoldingsREDMILE

Sleepiosleepio.cominJun 2020 · $39M

App to improve mental health and insomnia

Co-investorsIndex VenturesKaiser Permanente VenturesOctopus VenturesSamsung Next

Vapothermvapotherm.comin𝕏May 2020 · $87M

Vapotherm manufactures high-velocity therapy devices for respiratory distress treatment across patient populations.

HardwareHealthtechMedical DevicesExeter, US

JOSEPH ARMY(Executive Officer, Director)JOHN LANDRY(Executive Officer)in

BoardANTHONY ARNERICH(Director)JASON LETTMAN(Director)GEOFF PARDO(Director)inSAMUEL BRASCH(Director)

Co-investorsCross Creek AdvisorsKaiser Permanente VenturesQuestMark Partners3x5 PartnersMorgenthaler

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.